JLJeanne Lubbe

Jeanne Lubbe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jeanne Lubbe has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Malignant hilar biliary strictures: palliative drainage during end-of-life care

    by Haytham Bayadsi, Clara-Marie Clasen, Stefan Hofmeyr, Urda Kotze, Rene Krause, Jeanne Lubbe, Eduard Jonas

    To investigate predictive factors in patients with non-curable malignant hilar biliary obstruction (mHBO) and identify those with a life expectancy of 30 days or less, who would not benefit from palliative biliary drainage. A retrospective analysis of consecutive palliative patients undergoing percutaneous or endoscopic biliary drainage for mHBO at Groote Schuur and Tygerberg Hospitals, Cape Town, between 1 January 2015 and 1 January 2023. Demographic and baseline clinical parameters, laboratory test results, tumour characteristics and intervention type were compared in patients who survived ≤ 30 days to those who survived > 30 days after index intervention. A total of 294 patients were included in the study, of whom 135 survived ≤ 30 days and 159 > 30 days. Regression analysis using a Cox proportional hazard model showed that Eastern Cooperative Oncology Group performance status ≥ 2, strictures secondary to hepatocellular carcinoma, serum levels of albumin < 30 g/L and serum levels of total and conjugated bilirubin > 250 μmol/L predicted survival of ≤ 30 days. These predictive factors should be considered by the multidisciplinary team regarding the decision to perform biliary drainage during end-of-life care or rather proceed to solely medical and symptomatic relief in patients with non-curable mHBO.

  • Stakeholder engagement towards establishing a national thyroid cancer registry in South Africa

    by W Conradie, Kj Baatjes, L Martin, T Luvhengo, J Lübbe, E Archer

    Patient registries in South Africa (SA) are not common. This study explored the perceptions and experiences of thyroid clinicians and members of existing patient registries in SA, aiming to establish a national thyroid cancer registry. This was an exploratory qualitative study based on surveys and semi-structured interviews of participants' experiences treating thyroid cancer and using registries in general. Convenience sampling was performed for the surveys (n = 27) and purposive sampling for the interviews (n = 20). Data collection and analysis were conducted concurrently, facilitating an iterative process. The thematic analysis followed the steps outlined by Braun and Clarke. Four themes were identified. The South African healthcare system, the perceived value of a patient registry, the role of various stakeholders, and barriers to registry implementation. Participants expressed the value of registries in SA for both clinical and research purposes. However, concerns were raised regarding perceived challenges, such as resource and time constraints. Developing a national thyroid cancer registry in SA requires responsiveness to national and local challenges and opportunities, necessitating an adaptable registry format. The principle of a registry is strongly supported by clinician stakeholders. The registry, as a clinical note-keeping system, will optimise clinicians' time efficiency in patient care, and standardisation of radiology and pathology reporting across a uniform platform will enhance patient care and data entry. The benefits of a registry strongly outweigh the challenges as it facilitates the development of local guidelines, improves patient outcomes, and promotes collaborative research among endocrine clinicians.

  • Risk Factors for Unresected Gastric Adenocarcinoma in South Africa: A National Cancer Registry Analysis

    by Naeelah Parker, Neha Sangana, Cameron E. Gaskill, Mazvita Muchengeti, Wenlong C. Chen, Galya Chinnery, Jeanne Lubbe, Kathryn M. Chu

    PURPOSE: To describe the proportion of biopsy-proven gastric adenocarcinoma (GAC) that was surgically resected in South Africa (SA) and explore contributory factors for nonresection. METHODS: This was a national retrospective study of GAC from 2015 to 2020 in SA using data available from the National Cancer Registry. Risk factors for nonresection were modeled using logistic regression. RESULTS: 3,919 individuals had biopsy-proven GAC, and of these, 560 (13.4%) had a surgical resection. Black race (odds ratio [OR], 2.3; P < .001), female sex (OR, 1.3, P = .020), and being uninsured (OR, 3.7, P < .001) were associated with nonresection. Resection rates showed a nonlinear increasing trend over time. CONCLUSION: The majority of GACs in SA were not resected, and race, sex, and health insurance status were associated with nonresection. Additional research to understand ways to mitigate barriers related to social determinants of health are needed to make cancer care more equitable in SA.

  • Open Access

    Metabolic and bariatric surgery: Surgical options and outcomes

    by J Lubbe, J G M Smit, M Z Koto, M Conradie-Smit, W May

    RECOMMENDATIONS 1. MBS is recommended for individuals with a BMI >35 kg/m2, regardless of the presence, absence or severity of comorbidities,* to:a) reduce long-term overall mortality (Level 2b, Grade B)b) induce significantly better long-term weight loss compared with medical management alone (Level 1a, Grade A)[4]c) induce control and remission of T2DM, in combination with best medical management, over best medical management alone (Level 2a, Grade B)d) significantly improve QoL (Level 3, Grade C) e) induce long-term remission of most obesity-related diseases, including dyslipidaemia (Level 3, Grade C),[8] hypertension (Level 3, Grade C) and MASLD (Level 3, Grade C). 2.MBS should be considered for individuals with metabolic disease and a BMI of 30 - 34.9 kg/m2*. 3.We suggest that the choice of metabolic and bariatric procedure be decided according to the patient’s need, in collaboration with an experienced MDT (Level 4, Grade D, Consensus). 4.We suggest that adjustable gastric banding should not be offered owing to unacceptable complications and long-term failure (Level 4,Grade D). 5.We suggest that one-anastomosis gastric bypass should not be routinely offered owing to long-term complications in comparison with standard Roux-en-Y gastric bypass (Level 4, Grade D). *Recommendation 1 (Level 5, Grade D) and Recommendation 2 (Level 2a, Grade B).


  • Open Access

    Metabolic and bariatric surgery: Selection and preoperative work-up

    by J G M Smit, J Lubbe, A Murphy, K Mawson, M Z Koto, M Conradie-Smit, W May

    RECOMMENDATIONS 1. We suggest that a comprehensive medical and nutritional evaluation be completed and nutrient deficiencies corrected in candidates for MBS (Level 4, Grade D). 2. We suggest screening for and treatment of obstructive sleep apnoea in people seeking MBS (Level 4, Grade D). 3. Preoperative smoking cessation can minimise postoperative complications (Level 2a, Grade B).


  • Open Access

    The role of mental health in obesity management

    by K Mawson, E J Barnard, J Lubbe, M Conradie-Smit, W May

    RECOMMENDATIONS 1. We recommend regular monitoring of weight, glucose and lipid profile in people with a mental health diagnosis who are taking medications associated with weight gain (Level 3, Grade C). 2. Healthcare providers can consider both efficacy and effects on body weight when choosing psychiatric medications (Level 2a, Grade B). 3. Metformin and psychological treatment, such as CBT, should be considered for prevention of weight gain in people with severe mental illness who are treated with antipsychotic medications associated with weight gain (Level 1a, Grade A).

  • Open Access

    Prevention and harm reduction of obesity (clinical prevention)

    by Z Bayat, J Lubbe, M Conradie-Smit, W May

    KEY MESSAGES FOR HEALTHCARE PROVIDERS Obesity is a complex chronic disease in which abnormal or excess body fat (adiposity) impairs health, increases the risk of long-term medical complications, and reduces lifespan. Obesity arises from a complex interplay of genetic, biological, behavioural, psychosocial and environmental factors, and can develop via slow and steady weight gain over an extended period, or from rapid bursts of weight gain. Obesity prevention should take place in a range of settings that access whole populations or high-risk groups. The individual-based approach to prevention is primarily used by healthcare providers and targets those with the highest level of risk of obesity. The population-based approach addresses the behavioural, sociocultural and environmental factors that contribute to non-communicable diseases in populations, including obesity. Primary care clinicians have an important role in early identification of people living with obesity. Regular assessments of body weight are needed to catch early weight gain. (See the chapters ‘Assessment of people living with obesity’ and ‘Primary care and primary healthcare in obesity management’.) Primary care clinicians should initiate discussion around weight gain early and contemplate interventions that consider its complex causes, providing guidance beyond ‘eat less and move more’. Many medications are associated with weight gain side-effects that can contribute to long-term weight gain. The risks and benefits of such medications should be weighed up for each specific person before prescribing. Excess pregnancy weight gain and post-pregnancy weight retention are significantly reduced with behavioural interventions. Primary care clinicians should counsel women attending prenatal care not to exceed pregnancy weight gain guidelines, in the course of dietary, physical activity and psychological interventions during prenatal visits. Health benefits of smoking cessation outweigh the cardiovascular consequences associated with smoking cessation-related weight gain. Short-term behavioural interventions (generally 6 months or less) aimed at preventing weight gain during young adulthood, menopause, smoking cessation and breast cancer treatment have not yet been shown to be effective. Longer-term interventions are likely to be needed to properly examine strategies for preventing weight gain for many of these high-risk groups and in the general population.


  • Open Access

    Thyroid cancer pathology: Insights from a developing region

    by W Conradie, J Lübbe, L Martin, T Luvhengo, R Razack, A Afrogheh, F Crabbia, S Nayler, J Davies, K Baatjes

    Background. The South African (SA) health sector and laboratories comprise a dual system that includes public and private providers. SA studies illustrate diverse thyroid cancer incidence across provinces, with papillary thyroid cancer (PTC) more prevalent in urban provinces than follicular thyroid cancer (FTC) and anaplastic thyroid carcinoma. Objectives. To provide a deeper insight into the geographic intricacies of thyroid cancer types from public and private provider perspectives. Methods. This study investigated thyroid cancer pathology in SA between 2015 and 2019, overall and by province and facility type (private, public). Laboratories provided data in different formats, requiring manual processing. The data extracted included date of birth, sex, province, specimen type and final histology results. Results. A total of 14 157 reports were included, of which 3 235 were thyroid cancers. Multiple challenges were experienced in terms of data processing. The public sector contributed 53.6% of thyroid cancer cases. Preoperative cytology was performed in 19.8% of thyroid cancers, and was diagnostic in 23.6%. There was significantly more FTC in the public sector (20.8% v. 5.6%), and more PTC in the private sector (87.1% v. 55.2%). T3 tumours were most prevalent in the public sector (52.3%), and T1 tumours in the private (38.8%). Conclusion. The dual SA health system and the geographical distribution of the population appear to influence the pathological landscape of thyroid cancer. Standardised thyroid cancer reporting across all public and private laboratories in the form of a prospective national thyroid registry would allow for a more accurate evaluation of thyroid disease, ultimately improving thyroid cancer care in SA.

  • Open Access

    Optimising registrar research supervision: Quality, conflict management and best practices

    by Adetayo E. Obasa, Ts’ePo Motsohi, Marilize Burger, Jeanne Lübbe, Lizelle Van Wyk, Jacques Du Toit

    Completing a Master of Medicine (MMed) research assignment involves both financial and time commitments. In addition, it requires considerable collaboration among supervisors, registrars, research coordinators, assistants, nurses, and patients. Substantial professional effort is necessary for developing the research concept, reviewing relevant literature, formulating a research question, and designing an appropriate methodology. From this perspective, we reflect on a clinical research supervision workshop that focuses on establishing robust supervision and conflict management practices. The workshop aimed to enhance supervision capacity for MMed research, guiding students in scientific rigour and methodology. By addressing this need, we hope to improve research quality across South African faculties and develop a new generation of skilled clinician-researchers. Clinicians as supervisors, play a pivotal role in guiding students through their academic and professional journeys. Best practices include fostering open communication, setting clear expectations, and providing consistent feedback. Institutional support is crucial, offering resources and training to enhance supervisory skills.